The Heart Rhythm Society announced plans to develop a first-of-its-kind Pulsed Field Ablation data collection platform (registry), sponsored in part by Johnson & Johnson MedTech, a global leader in the treatment of heart rhythm disorders. The platform will offer a national, technology-enabled infrastructure designed to advance clinical evidence, improve patient outcomes, and support post-market surveillance for atrial fibrillation PFA procedures.
Read the full press release here: https://bit.ly/4qijiQQ
Listen on:
Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
Resource Type
- HRStv Podcast
Related Resources
HRStv Podcast
Episode 171: CIED Lead Management 2026 – Real-World Consequences & Clinical Impact
Oliver J. Monfredi, MBChB, PhD, FHRS, talks with Emily P. Zeitler, MD,…
May 15, 2026
HRStv Podcast
Episode 170: Final Results of the LEADR LBBAP clinical trial
Recorded at #HRS2026 in Chicago, #HRStv host Oliver J. Monfredi, MBChB, PhD,…
May 12, 2026
HRStv Podcast
Episode 169: CIED Lead Management in 2026 – What’s Changed and How It Impacts Practice
Mikhael F. El-Chami, MD, FHRS, talks with Yong-Mei Cha, MD, FHRS, and…
May 11, 2026